84-1195-50 USP9X (Probable Ubiquitin Carboxyl-Terminal Hydrolase FAF-X, Ubiquitin Thioesterase FAF-X, Ubiquitin-specific-processing Protease FAF-X, Deubiquitinating Enzyme FAF-X, Ubiquitin-specific Protease 9, X Chromosome, Fat fAcets Protein-related, X-linked, Fat Facets in Mammals, hFAM, DFFRX, FAM, USP9) 100ul U4099-67A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Protein ubiquitination and deubiquitination is a reversible process catalyzed by ubiquitinating enzymes (UBEs) and deubiquitinating enzymes (DUBs) (1,2).
  • DUBs are categorized into five subfamiles-USP, UCH, OTU, MJD, and JAMM.
  • USP9X/hFAM is an X-linked member of the ubiquitin-specific protease (USP) subfamily of DUBs and possesses a well-conserved catalytic domain with cysteine peptidase activity, which allows for cleavage of ubiquitin and polyubiquitin conjugates.
  • USP9X is the mammalian homolog of the Drosophila fat-facets (faf) gene, which is essential for normal eye development and viability of the early fly embryo (3,4).
  • While USP9X expression is also critical for normal mammalian development (5-7), many of its substrates are only beginning to be elucidated.
  • There is mounting evidence that USP9X functions in the formation of cell-cell contacts during the polarization of epithelial cells, in part through deubiquitination-dependent stabilization of molecules involved in maintaining the integrity of both adherens and tight junctions.
  • Indeed, USP9X has been found to associate with AF-6, the b-catenin-E-cadherin complex, and EFA6 (8-11).
  • Studies have also demonstrated that USP9X is an integral component of the TGF-b/BMP signaling cascade and regulates TGF-b responsiveness by opposing TRIM33-mediated monoubiquitination of SMAD4 (12).
  • Recently, USP9X was shown to be overexpressed in a variety of human cancers, which was linked to enhanced cell survival and chemoresistance through its ability to deubiquitinate and stabilize the Mcl-1 oncoprotein.
  • This evidence supports USP9X as a therapeutic target in the context of human malignancies such as follicular lymphomas and diffuse large B-cell lymphomas (13).
  • Applications:Suitable for use in Western Blot.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:1000, incubate membrane with diluted antibody in 5% w/v BSA, 1X TBS, 0.1% Tween-20 at 4°C with gentle shaking, overnight
  • Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for at least 12 months.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A and peptide affinity chromatography.
  • Form:Supplied as a liquid in 10mM HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol.
  • Specificity:Recognizes endogenous levels of total human USP9X. Species Crossreactivity: mouse, rat, monkey and canine.
  • Isotype:IgG
  • Calc Applications Abbrev:WB
  • Calc Crossreactivity:Ca Hu Mk Mo Rt
  • Immunogen:Synthetic peptide corresponding to residues surrounding Phe2130 of human USP9X.
  • Shelf Life:1year
  • Swiss Prot Number:Q93008
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1195-50
型番
U4099-67A
入り数
1個
標準価格
176,000円(税抜)
WEB価格
-円
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る